On the latest episode of The Cannabis Conversation, we’re joined by Dr Sung Min Pyo – Head of Laboratory – Enabling Pharma Excipients for BASF.
A 2018 report from the World Health Organisation (WHO) estimated the bioavailability from oral consumption of CBD to be only 6% (WHO Technical Report Series 1013)
We explore the reasons behind this estimate and discuss the bioavailability, absorption, and solubility of CBD, alongside some potential solutions to improve its uptake in the body.
The Cannabis Conversation is sponsored by EVO NXT – the business festival for Next Generation Products (NGP). The festival offers: modern live communication with experts and big-name speakers, key note talks, summits, workshops, panel dicussions and entertainment!
More information: www.evo-nxt.com
Secure your ticket now: www.evo-nxt.com/ticketshop
Get in touch at www.luminorecruit.com.
Subscribe on Apple Podcasts | Spotify | Google Podcasts | Amazon Music | Stitcher | Deezer
About Dr. Sung Min Pyo
Dr. Sung Min Pyo holds a PhD in Pharmacy and has dedicated her career to making the world a healthier place. As an expert in the field of bioavailability, she develops novel drug delivery systems that fundamentally improve the uptake and thus the efficacy of drugs in the body. As a consultant to pharmaceutical companies and public institutions, and as a head of laboratory at BASF, she has an in-depth understanding of how to bring innovative ideas to the finished product that truly improves people’s lives.
Resources
Connect with Dr. Sung Min Pyo on LinkedIn: https://www.linkedin.com/in/sung-min-pyo
About Anuj
I’m Anuj Desai – a lawyer and Head of Commercial Partnerships for Knowde Group – a life sciences CRO and strategic consultancy focused on plant based therapeutics and psychedelics
Please follow The Cannabis Conversation to keep up to date with news and insights from the industry, and get in touch at anuj@canverse.global to discuss how I can help your business move forward in the cannabis sector!